In pancreatic ductal adenocarcinoma (PDAC), the concentrations of BCAA levels are significantly elevated, which is associated with tumor growth and development because BCAT2 is upregulated in PDAC, and the inhibition of this enzyme is associated with suppressing PDAC progression (51, 52). This evidence concerns the gene BCAT2 and neoplasm.